Searching News Database: BD
HSMN NewsFeed - 25 Jul 2024
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
HSMN NewsFeed - 7 Dec 2023
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
HSMN NewsFeed - 30 Nov 2023
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
HSMN NewsFeed - 7 Aug 2023
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
HSMN NewsFeed - 1 Aug 2023
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
HSMN NewsFeed - 24 Jul 2023
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris(TM) Infusion System
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris(TM) Infusion System
HSMN NewsFeed - 16 May 2023
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
HSMN NewsFeed - 13 Sep 2022
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
HSMN NewsFeed - 30 Jun 2022
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
HSMN NewsFeed - 12 May 2022
BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
HSMN NewsFeed - 25 Apr 2022
New BD Reagents Enable Researchers to Break Through Resolution Boundaries in Flow Cytometry
New BD Reagents Enable Researchers to Break Through Resolution Boundaries in Flow Cytometry
HSMN NewsFeed - 9 Mar 2022
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
HSMN NewsFeed - 3 Jan 2022
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD
HSMN NewsFeed - 17 Dec 2021
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
HSMN NewsFeed - 9 Dec 2021
BD Acquires Tissuemed, Ltd. to Add Advanced Sealant to its Portfolio of Surgical Solutions
BD Acquires Tissuemed, Ltd. to Add Advanced Sealant to its Portfolio of Surgical Solutions
HSMN NewsFeed - 2 Dec 2021
BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease
BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease
HSMN NewsFeed - 24 Nov 2021
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
BD Names Francesca DeMartino as Senior Vice President of Investor Relations
HSMN NewsFeed - 26 Oct 2021
BD Begins Shipments Of First Smartphone Interpreted Over-The-Counter Rapid COVID-19 Test
BD Begins Shipments Of First Smartphone Interpreted Over-The-Counter Rapid COVID-19 Test
HSMN NewsFeed - 6 Oct 2021
BD Announces 510(k) Clearance of Expanded Indications for the Rotarex(TM) Atherectomy System
BD Announces 510(k) Clearance of Expanded Indications for the Rotarex(TM) Atherectomy System
HSMN NewsFeed - 25 Aug 2021
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
HSMN NewsFeed - 27 Jul 2021
BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration
BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration
HSMN NewsFeed - 25 May 2021
BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System
BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System
HSMN NewsFeed - 29 Apr 2021
BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula
BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula
HSMN NewsFeed - 15 Apr 2021
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
HSMN NewsFeed - 6 Apr 2021
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
HSMN NewsFeed - 30 Sep 2020
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes
HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
HSMN NewsFeed - 7 Jul 2020
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
HSMN NewsFeed - 1 Jul 2020
Hallura Announces the Appointment of Paul Navarre to Its Board of Directors
Hallura Announces the Appointment of Paul Navarre to Its Board of Directors
HSMN NewsFeed - 3 Apr 2020
BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
HSMN NewsFeed - 31 Oct 2019
Stryker receives FDA clearance for SAHARA(R) Lateral 3D Expandable Interbody System
Stryker receives FDA clearance for SAHARA(R) Lateral 3D Expandable Interbody System
HSMN NewsFeed - 20 Mar 2019
Petra Pharma announces licensing agreement with Takeda Pharmaceutical Company
Petra Pharma announces licensing agreement with Takeda Pharmaceutical Company
HSMN NewsFeed - 14 Mar 2019
BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease
BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease
HSMN NewsFeed - 24 Jan 2019
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
HSMN NewsFeed - 29 Nov 2018
BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion
BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion
HSMN NewsFeed - 23 Oct 2018
BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)
BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)
HSMN NewsFeed - 7 Sep 2018
Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD
Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD
HSMN NewsFeed - 9 Jul 2018
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
HSMN NewsFeed - 24 May 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
HSMN NewsFeed - 27 Apr 2018
Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer
Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer
HSMN NewsFeed - 20 Feb 2018
Peritech Pharma's Novel Hemorrhoids Treatment Commercialized in 24 Countries
Peritech Pharma's Novel Hemorrhoids Treatment Commercialized in 24 Countries
HSMN NewsFeed - 15 Jan 2018
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
HSMN NewsFeed - 12 Jan 2018
BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
HSMN NewsFeed - 16 Nov 2017
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines
HSMN NewsFeed - 20 Jun 2017
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
HSMN NewsFeed - 9 May 2017
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
HSMN NewsFeed - 22 Feb 2017
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
BD Veritor(TM) System Meets FDA's New Performance Requirements for Rapid Influenza Antigen Detection Tests
HSMN NewsFeed - 8 Nov 2016
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
HSMN NewsFeed - 26 Oct 2015
CareFusion Signs Exclusive Distribution Agreement With AAM Healthcare For Video Laryngoscope
CareFusion Signs Exclusive Distribution Agreement With AAM Healthcare For Video Laryngoscope
HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
HSMN NewsFeed - 10 Jun 2015
Panasonic Healthcare and Bayer Diabetes Care to Create Leading Global Diabetes Care Solutions Business
Panasonic Healthcare and Bayer Diabetes Care to Create Leading Global Diabetes Care Solutions Business
HSMN NewsFeed - 23 Sep 2014
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
HSMN NewsFeed - 6 Aug 2014
BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
HSMN NewsFeed - 28 Jul 2014
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
HSMN NewsFeed - 7 Feb 2014
Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development
Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development
HSMN NewsFeed - 13 Jan 2014
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
HSMN NewsFeed - 3 Dec 2013
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
HSMN NewsFeed - 21 Oct 2013
Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
HSMN NewsFeed - 3 Oct 2013
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
HSMN NewsFeed - 16 Sep 2013
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
FDA Grants Soligenix Orphan Drug Designation for SGX94 for Treatment of Acute Radiation Syndrome
HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
HSMN NewsFeed - 11 Apr 2013
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS(TM) Passive Needle Guard
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS(TM) Passive Needle Guard
HSMN NewsFeed - 27 Mar 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
HSMN NewsFeed - 27 Feb 2013
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Regional Anesthesia Trays
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Regional Anesthesia Trays
HSMN NewsFeed - 4 Feb 2013
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
HSMN NewsFeed - 15 Oct 2012
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
HSMN NewsFeed - 2 Aug 2010
BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform
BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform
HSMN NewsFeed - 29 Jul 2010
BD Announces Appointment of Zachary A. Nagle as Vice President, Investor Relations
BD Announces Appointment of Zachary A. Nagle as Vice President, Investor Relations
HSMN NewsFeed - 29 Jul 2010
BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer
BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer
HSMN NewsFeed - 26 Oct 2009
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
HSMN NewsFeed - 29 Jun 2009
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
HSMN NewsFeed - 17 Mar 2009
HyperBranch Medical Technology, Inc. Licenses OcuSeal Liquid Ocular Bandage to BD
HyperBranch Medical Technology, Inc. Licenses OcuSeal Liquid Ocular Bandage to BD
HSMN NewsFeed - 13 Mar 2009
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
HSMN NewsFeed - 12 Jan 2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
HSMN NewsFeed - 6 Jan 2009
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
DOR BioPharma Obtains Fast Track Designation for DOR201 in the Prevention of Acute Radiation Enteritis
HSMN NewsFeed - 5 Nov 2008
BD Announces Executive Appointments of President and Chief Financial Officer
BD Announces Executive Appointments of President and Chief Financial Officer
HSMN NewsFeed - 3 Sep 2008
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
HSMN NewsFeed - 26 Aug 2008
BD (Becton, Dickinson and Company) Licenses Intellectual Property to Ivera Medical Corporation
BD (Becton, Dickinson and Company) Licenses Intellectual Property to Ivera Medical Corporation
HSMN NewsFeed - 14 Aug 2008
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 28 Jul 2008
Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
HSMN NewsFeed - 9 Jun 2008
Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntington's Disease
Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntington's Disease
HSMN NewsFeed - 22 May 2008
DOR BioPharma Provides Update on orBec(R) European Regulatory and Development Strategy
DOR BioPharma Provides Update on orBec(R) European Regulatory and Development Strategy
HSMN NewsFeed - 1 Apr 2008
ACIST Medical Systems Enhances Portfolio with Acquisition of E-Z-EM Products and Systems
ACIST Medical Systems Enhances Portfolio with Acquisition of E-Z-EM Products and Systems
HSMN NewsFeed - 31 Mar 2008
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
HSMN NewsFeed - 18 Mar 2008
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
HSMN NewsFeed - 10 Jan 2008
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
HSMN NewsFeed - 14 Dec 2007
Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
HSMN NewsFeed - 15 Nov 2007
Intranasal Therapeutics, Inc. Names Vice Presidents of Pharmaceutical Development and Commercial Development
Intranasal Therapeutics, Inc. Names Vice Presidents of Pharmaceutical Development and Commercial Development
HSMN NewsFeed - 30 Oct 2007
Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash
Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash
HSMN NewsFeed - 9 Oct 2007
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
HSMN NewsFeed - 8 Oct 2007
BrainStorm on the Verge of a Breakthrough Towards Developing a Cure for Lou Gehrig's Disease
BrainStorm on the Verge of a Breakthrough Towards Developing a Cure for Lou Gehrig's Disease
HSMN NewsFeed - 4 Oct 2007
New Contracted Supplier Added to Premier's New Safety IV Catheter Agreements
New Contracted Supplier Added to Premier's New Safety IV Catheter Agreements
HSMN NewsFeed - 20 Sep 2007
Hospitals, Healthcare Providers to Save With Premier's Safety IV Catheter Agreements
Hospitals, Healthcare Providers to Save With Premier's Safety IV Catheter Agreements
HSMN NewsFeed - 5 Sep 2007
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
HSMN NewsFeed - 4 Sep 2007
CardioDynamics Receives Shareholder Approval and Completes Sale of Vermed Business
CardioDynamics Receives Shareholder Approval and Completes Sale of Vermed Business
HSMN NewsFeed - 21 Aug 2007
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
HSMN NewsFeed - 14 Aug 2007
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
HSMN NewsFeed - 7 Aug 2007
BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology Officer
BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology Officer
HSMN NewsFeed - 29 Jun 2007
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
HSMN NewsFeed - 28 Jun 2007
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
HSMN NewsFeed - 17 May 2007
Cortex's AMPAKINE(R) Drug May Offer New Hope for Memory Problems Associated with Huntington's Disease
Cortex's AMPAKINE(R) Drug May Offer New Hope for Memory Problems Associated with Huntington's Disease
HSMN NewsFeed - 15 May 2007
Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing
Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing
HSMN NewsFeed - 14 May 2007
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
HSMN NewsFeed - 9 May 2007
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
HSMN NewsFeed - 30 Apr 2007
Tengion Names Dr. Sharon Presnell as VP for Regenerative Medicine & Biology
Tengion Names Dr. Sharon Presnell as VP for Regenerative Medicine & Biology
HSMN NewsFeed - 25 Apr 2007
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
HSMN NewsFeed - 10 Apr 2007
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
HSMN NewsFeed - 8 Mar 2007
Siemens Completes Acquisition of the BD.id(TM) System for Patient Identification and Specimen Management
Siemens Completes Acquisition of the BD.id(TM) System for Patient Identification and Specimen Management
HSMN NewsFeed - 12 Feb 2007
Benda Pharmaceutical, Inc. Appoints Eric Yu Tak Shing as Its Chief Financial Officer
Benda Pharmaceutical, Inc. Appoints Eric Yu Tak Shing as Its Chief Financial Officer
HSMN NewsFeed - 31 Jan 2007
FDA Advisory Committee to Review DOR BioPharma's orBec(R) for the Treatment of GI GVHD
FDA Advisory Committee to Review DOR BioPharma's orBec(R) for the Treatment of GI GVHD
HSMN NewsFeed - 17 Jan 2007
Bradley Pharmaceuticals Welcomes Alton Delane, Vice President, Business Development
Bradley Pharmaceuticals Welcomes Alton Delane, Vice President, Business Development
HSMN NewsFeed - 16 Jan 2007
Non-Invasive Monitoring Systems, Inc. Announces Appointment of Gary Wetstein as Chief Financial Officer
Non-Invasive Monitoring Systems, Inc. Announces Appointment of Gary Wetstein as Chief Financial Officer
HSMN NewsFeed - 10 Jan 2007
Bradley Pharmaceuticals Announces Appointment of Dr. Leonard S. Jacob As Non-Executive Chair
Bradley Pharmaceuticals Announces Appointment of Dr. Leonard S. Jacob As Non-Executive Chair
HSMN NewsFeed - 29 Dec 2006
Bradley Pharmaceuticals Announces Launch of Authorized Generic of Pamine(R) (methscopolamine bromide)
Bradley Pharmaceuticals Announces Launch of Authorized Generic of Pamine(R) (methscopolamine bromide)
HSMN NewsFeed - 19 Dec 2006
TriPath Imaging Stockholders Approve Merger With Becton, Dickinson and Company
TriPath Imaging Stockholders Approve Merger With Becton, Dickinson and Company
HSMN NewsFeed - 19 Dec 2006
Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)
Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)
HSMN NewsFeed - 28 Nov 2006
European Medicines Agency Accepts DOR BioPharma's MAA Filing for orBec(R)
European Medicines Agency Accepts DOR BioPharma's MAA Filing for orBec(R)
HSMN NewsFeed - 7 Nov 2006
DOR BioPharma Submits European Marketing Application for orBec(R) to Treat GI Graft-Versus-Host Disease
DOR BioPharma Submits European Marketing Application for orBec(R) to Treat GI Graft-Versus-Host Disease
HSMN NewsFeed - 2 Oct 2006
Alert for BD Logic(R) Meter Users: Roche Diagnostics Offers ACCU-CHEK(R) Blood Glucose Systems
Alert for BD Logic(R) Meter Users: Roche Diagnostics Offers ACCU-CHEK(R) Blood Glucose Systems
HSMN NewsFeed - 29 Sep 2006
Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) Patients
Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) Patients
HSMN NewsFeed - 22 Sep 2006
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
HSMN NewsFeed - 19 Sep 2006
PhytoMedical Announces Appointment of Senior Pharmaceutical Executives to Board of Directors
PhytoMedical Announces Appointment of Senior Pharmaceutical Executives to Board of Directors
HSMN NewsFeed - 5 Jul 2006
Cardinal Health Aligns Manufacturing Businesses, Names International President
Cardinal Health Aligns Manufacturing Businesses, Names International President
HSMN NewsFeed - 31 May 2006
SHPI Enters OEM Supply Agreement with ICU Medical for SecureLoc(TM) Safety Introducer Needle
SHPI Enters OEM Supply Agreement with ICU Medical for SecureLoc(TM) Safety Introducer Needle
HSMN NewsFeed - 15 May 2006
ESBATech AG Announces Appointment of James Egan as Chief Business Officer
ESBATech AG Announces Appointment of James Egan as Chief Business Officer
Additional items found! 129
Members Archive contains
129 additional stories matching:
BD
(Password required)
BD
(Password required)